American Assets Investment Management LLC bought a new stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) during the second quarter, according to its most recent 13F filing with the SEC. The fund bought 75,720 shares of the company’s stock, valued at approximately $3,739,000. American Assets Investment Management LLC owned 0.09% of Acadia Healthcare as of its most recent filing with the SEC.

Several other hedge funds have also made changes to their positions in ACHC. Russell Investments Group Ltd. boosted its stake in shares of Acadia Healthcare by 43.9% in the first quarter. Russell Investments Group Ltd. now owns 221,649 shares of the company’s stock valued at $9,664,000 after buying an additional 67,665 shares in the last quarter. Emerald Advisers Inc. PA raised its stake in Acadia Healthcare by 2.3% in the first quarter. Emerald Advisers Inc. PA now owns 85,198 shares of the company’s stock worth $3,715,000 after buying an additional 1,876 shares during the period. UBS Asset Management Americas Inc. raised its stake in Acadia Healthcare by 21.6% in the first quarter. UBS Asset Management Americas Inc. now owns 332,355 shares of the company’s stock worth $14,491,000 after buying an additional 59,001 shares during the period. Schwab Charles Investment Management Inc. raised its stake in Acadia Healthcare by 2.8% in the first quarter. Schwab Charles Investment Management Inc. now owns 290,396 shares of the company’s stock worth $12,662,000 after buying an additional 7,985 shares during the period. Finally, Vanguard Group Inc. raised its stake in Acadia Healthcare by 8.1% in the first quarter. Vanguard Group Inc. now owns 5,743,233 shares of the company’s stock worth $250,404,000 after buying an additional 431,550 shares during the period.

Acadia Healthcare Company, Inc. (NASDAQ ACHC) opened at 52.20 on Wednesday. The stock has a market capitalization of $4.59 billion, a price-to-earnings ratio of 573.63 and a beta of 1.15. The stock’s 50 day moving average is $50.54 and its 200-day moving average is $44.94. Acadia Healthcare Company, Inc. has a 12 month low of $32.54 and a 12 month high of $54.34.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings results on Thursday, July 27th. The company reported $0.66 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.65 by $0.01. The business had revenue of $715.90 million for the quarter, compared to the consensus estimate of $717.38 million. Acadia Healthcare had a net margin of 0.30% and a return on equity of 8.69%. The business’s revenue was down 5.4% on a year-over-year basis. During the same period in the previous year, the firm earned $0.73 EPS. On average, equities research analysts expect that Acadia Healthcare Company, Inc. will post $2.45 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this piece of content on another publication, it was copied illegally and republished in violation of United States & international copyright & trademark legislation. The legal version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/08/16/75720-shares-in-acadia-healthcare-company-inc-achc-acquired-by-american-assets-investment-management-llc.html.

A number of analysts recently weighed in on ACHC shares. Jefferies Group LLC reissued a “buy” rating on shares of Acadia Healthcare in a research report on Monday, May 15th. Zacks Investment Research lowered shares of Acadia Healthcare from a “buy” rating to a “hold” rating in a research report on Tuesday, August 1st. William Blair started coverage on shares of Acadia Healthcare in a research report on Tuesday, July 18th. They issued an “outperform” rating on the stock. BidaskClub lowered shares of Acadia Healthcare from a “buy” rating to a “hold” rating in a research report on Monday, July 31st. Finally, Cantor Fitzgerald reissued a “hold” rating and issued a $45.00 price objective on shares of Acadia Healthcare in a research report on Wednesday, April 26th. Five investment analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company. The company currently has an average rating of “Buy” and a consensus target price of $59.21.

In other news, insider Scott Schwieger sold 2,891 shares of the business’s stock in a transaction that occurred on Monday, July 31st. The shares were sold at an average price of $52.85, for a total value of $152,789.35. Following the sale, the insider now directly owns 8,841 shares of the company’s stock, valued at approximately $467,246.85. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director William Grieco sold 2,000 shares of the business’s stock in a transaction that occurred on Friday, June 16th. The shares were sold at an average price of $45.42, for a total transaction of $90,840.00. Following the completion of the sale, the director now directly owns 47,013 shares in the company, valued at $2,135,330.46. The disclosure for this sale can be found here. Insiders sold a total of 2,138,347 shares of company stock worth $105,486,669 over the last three months. Insiders own 11.10% of the company’s stock.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.

Institutional Ownership by Quarter for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Stock Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related stocks with our FREE daily email newsletter.